Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO Trial)

NCT06091826 is registered in ClinicalTrials.gov with NFL Biosciences SAS as lead sponsor.

NCT NCT06091826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06091826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO Trial)
Lead sponsor
NFL Biosciences SAS
Phase
Phase 2
Overall status
Completed
Start date
February 21, 2023
Completion date
September 30, 2023
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, smoking cessation